Discover MichBio, Michigan's bioscience industry leader. Explore membership benefits, events, advocacy efforts, and the latest news on drug...
Read PostAdvocacy
Championing Bio-Industry Progress
Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.
Join MichBio in advocating for the medtech industry! Discover our initiatives, events, and membership benefits to support innovation in Michigan's...
Read PostStay updated on Michigan's Earned Sick Time Act changes, including new employer requirements and employee rights. Learn how these updates impact...
Read PostAdvocate for bioscience funding in Michigan! Learn how to contact your Congressional representatives and support vital biomedical research...
Read PostExplore MichBio's insights on federal advocacy for 2025, focusing on policy impacts, tax reforms, and industry growth strategies in the biosciences...
Read PostExplore Michigan's evolving legislative landscape and its impact on the life sciences industry. Stay informed on key policies, advocacy efforts, and...
Read PostGovernor Whitmer signs bipartisan bills establishing the Michigan Innovation Fund and R&D Tax Credit to boost entrepreneurship, lower business...
Read PostExplore MichBio's resources for the bio-industry, including membership benefits, events, advocacy, and the latest news on medical technology...
Read PostStay updated on Michigan's Personal Data Privacy Act, its implications for the medtech industry, and advocacy efforts by MichBio and AdvaMed.
Read PostStay informed on the "Ensuring Patient Access to Critical Breakthrough Products Act," aimed at expediting Medicare coverage for innovative medical...
Read PostJoin the Michigan Rare Disease Advisory Council (MI RDAC) as it amplifies advocacy for rare diseases, collaborating with state government and...
Read PostStay updated on MichBio's advocacy efforts for R&D tax relief and the impact of Section 174 on life science companies. Join us in pushing for change!
Read Post